The global aquaculture vaccines market size is expected to reach USD 605.4 million by 2028, according to a new report by Grand View Research. It is expected to expand at a CAGR of 8.4% from 2021 to 2028. The advent of vaccines for fish has significantly reduced the dependency on antimicrobial agents. Vaccination programs help in protecting the animal health and livelihoods of those who work with livestock as well as aid in ensuring food security. The development of some aquaculture sectors, such as the salmon industry in Norway, wherein fish farmers in the country moved from using antibiotics to vaccines by 1994, demonstrates the potential of vaccines in reducing the dependence on veterinary medicines.
Similar to other markets, the market for aquaculture vaccines has also been significantly affected. Some of the major impacts of COVID-19 on the market include supply chain disruptions, a decline in sales, low demand, growing awareness of animal to human disease transmission risks, and operational hurdles due to changing policies and restrictions.
The growing demand for aquatic animal-derived food products, such as oil, caviar, protein powders, and meat, is encouraging farmers to use vaccinations for aquaculture to gain higher profitability. Due to the rising urbanization, consumers are becoming more aware of the nutritious value of animal protein. The demand for healthy, sustainable, and high-quality meat products that have fewer or no drugs is also increasing rapidly. Thus, the need for healthy breeding of aquatic animals is increasing, which is expected to fuel the demand for aquaculture vaccines, thereby boosting the market growth.
The market for aquaculture vaccines is fairly competitive. The most notable participants in the market are Zoetis; Merck & Co., Inc.; and Elanco, along with other manufacturers of aquaculture vaccines. These players are involved in new product launches, acquisitions, and partnerships to gain a competitive edge over each other. For instance, in July 2020, Zoetis acquired Fish Vet Group from Benchmark Holdings, PLC. This added to the company’s Pharmaq business, which is involved in fish vaccines and services.
Request a free sample copy or view report summary: Aquaculture Vaccines Market Report
Based on product, the inactivated vaccines segment held the largest share in 2020 owing to its high acceptance globally
By route of administration, the injected segment held the largest market share in 2020 owing to its easy availability
The bacterial application segment held the largest revenue share in 2020 owing to the high prevalence of bacterial diseases in aquatic species
In 2020, Europe held the largest revenue share owing to the increasing adoption of aquaculture vaccines, especially in countries such as Norway and the U.K.
North America held the second-largest revenue share in 2020. The key driver in this regional market is the presence of major market players, especially in the U.S.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to the rise in aquaculture production and favorable government initiatives, especially in developing countries
Grand View Research has segmented the global aquaculture vaccines market report on the basis of product, route of administration, application, and region:
Aquaculture Vaccines Product Outlook (Revenue, USD Million, 2016 - 2028)
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
Aquaculture Vaccines Route Of Administration Outlook (Revenue, USD Million, 2016 - 2028)
Oral
Injected
Immersion & Spray
Aquaculture Vaccines Application Outlook (Revenue, USD Million, 2016 - 2028)
Bacterial
Viral
Parasitic
Aquaculture Vaccines Regional Outlook (Revenue, USD Million, 2016 - 2028)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Norway
Denmark
Ireland
Eastern Europe
Croatia
Czech Republic
Hungary
Poland
Russia
Romania
Bulgaria
Asia Pacific
Japan
South Korea
Taiwan
Indonesia
Malaysia
Singapore
Thailand
Philippines
Vietnam
Latin America
Brazil
Mexico
Argentina
Chile
Colombia
Peru
Ecuador
Middle East & Africa
South Africa
Saudi Arabia
Israel
Egypt
List of Key Players of Aquaculture Vaccines Market
Zoetis
Phibro Animal Health Corporation
Elanco
Merck & Co., Inc.
KBNP
CAVAC
Kyoto Biken Laboratories, Inc.
Nisseiken Co., Ltd.
Vaxxinova International BV
HIPRA
"The quality of research they have done for us has been excellent..."